Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04897776 · ClinicalTrials.gov registry record · NA
Stimulation of the Thalamus for Arousal Restoral in Temporal Lobe Epilepsy
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04897776 is a NA study that has completed, run by Yale University. The registered enrollment target is 5 participants.
The verdict
NCT04897776, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The goal is to provide a novel therapeutic option for temporal lobe epilepsy patients when focal impaired awareness seizures cannot be stopped by medications, surgical or laser ablation, or by neurostimulation. The goal is restore consciousness when seizures cannot be stopped. If successful, addition of bilateral thalamic stimulation to existing responsive neurostimulation to rescue consciousness would greatly alter clinical practice and patient outcomes. Importantly, previous approaches aim to stop seizures, whereas this study aims to use thalamic stimulation to improve a major negative consequence when seizures cannot be stopped. The potential impact extends beyond temporal lobe epilepsy to other seizure types, and may also extend more broadly to inform treatment of other brain disorders associated with impaired consciousness and cognition.
Interventions
- DEVICE Central Thalamic Stimulation
- DEVICE Hippocampal Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-10-31 |
| Est. Completion | 2025-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04897776
The ClinicalTrials.gov registry entry for NCT04897776 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Central Thalamic Stimulation is the first listed.
NCT04897776 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04897776 about?
NCT04897776 is a clinical study titled "Stimulation of the Thalamus for Arousal Restoral in Temporal Lobe Epilepsy". The goal is to provide a novel therapeutic option for temporal lobe epilepsy patients when focal impaired awareness seizures cannot be stopped by medications, surgical or laser ablation, or by neurostimulation. The goal is restore consciousness when seizures cannot be stopped. If successful, additio...
What is the current status of trial NCT04897776?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2021-10-31. Estimated completion is 2025-07-15.
What interventions are being tested in trial NCT04897776?
The interventions under investigation include: Central Thalamic Stimulation (DEVICE), Hippocampal Stimulation (DEVICE).
Who is sponsoring clinical trial NCT04897776?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.